Back to DRIEHAUS CAPITAL MANAGEMENT LLC

SYRE
Showing 8 of 11 quarters

Position history for DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in SPYRE THERAPEUTICS INC

DRIEHAUS CAPITAL MANAGEMENT LLC holds 2.8M shares of SYRE (SPYRE THERAPEUTICS INC), worth $140.8M as of 2026-Q1. The position was decreased (-3.2% shares). SYRE represents 1.0% of DRIEHAUS CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$140.8M

Current Shares

2.8M

Total Value Change

+$124.6M

Total Shares Change

+2.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
2.8M
-3.2%
$140.8M1.0%$40.07
0
2025-Q4
Increased
2.9M
+39.9%
$94.4M0.6%$31.88
56
2025-Q3
Decreased
2.1M
-1.2%
$34.5M0.2%$16.36
0
2025-Q2
Decreased
2.1M
-23.3%
$31.2M0.2%$15.22
0
2025-Q1
Decreased
2.7M
-3.1%
$43.8M0.4%$17.94
0
2024-Q4
Increased
2.8M
+308.1%
$65.3M0.5%$22.54
67
2024-Q3
Unchanged
687,080
0.0%
$20.2M0.2%$28.49
0
2024-Q2
Unchanged
687,080
0.0%
$16.2M0.2%$23.51
0

Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used